10.6084/m9.figshare.8186843.v1
Marija V. Anđelković
Marija V.
Anđelković
Slobodan M. Janković
Slobodan M.
Janković
Marina J. Kostić
Marina J.
Kostić
Radica S. Živković Zarić
Radica S. Živković
Zarić
Valentina D. Opančina
Valentina D.
Opančina
Miloš Ž. Živić
Miloš Ž.
Živić
Marko J. Milosavljević
Marko J.
Milosavljević
Ana V. Pejčić
Ana V.
Pejčić
Antimicrobial treatment of <i>Stenotrophomonas maltophilia</i> invasive infections: Systematic review
Taylor & Francis Group
2019
Stenotrophomonas maltophilia
invasive infections
systematic review
antibiotic treatment
2019-05-25 07:27:08
Dataset
https://tandf.figshare.com/articles/dataset/Antimicrobial_treatment_of_i_Stenotrophomonas_maltophilia_i_invasive_infections_Systematic_review/8186843
<p><i>Stenotrophomonas maltophilia</i> can cause serious infections in immunocompromised patients. The aim of this systematic review was to establish what invasive infections in humans are caused by <i>S. maltophilia</i> and to evaluate the optimal choice of antibiotics for their treatment. MEDLINE, EBSCO, SCOPUS, SCINDEKS and GOOGLE SCHOLAR were systematically searched for clinical trials, observational studies, case reports or case series describing invasive infections with <i>S. maltophilia</i> in patients of any age. <i>S. maltophilia</i> may cause invasive infections of various tissues in hospitalized patients. In the great majority of cases it was susceptible to co-trimoxazole, levofloxacin and ceftazidime. In about three fourths of the cases, the treatment was successful, while less than 20% of the patients died. <i>S. maltophilia</i> is increasingly associated with serious invasive infections in hospitalized patients and due to growing trend of resistance to almost all antibiotics requires a careful approach to patients who is harboring this bacterium.</p>